• EZ Cap™ Firefly Luciferase mRNA (5-moUTP): Mechanism & Bench

  2026-08-04

  EZ Cap™ Firefly Luciferase mRNA (5-moUTP) is a 5-moUTP modified, in vitro transcribed mRNA designed for robust gene expression with enhanced stability and minimized innate immune activation. Its Cap1 structure and poly(A) tail optimize translation efficiency, making it a gold-standard bioluminescent reporter for mRNA delivery and gene regulation studies.

• Ibrexafungerp in Antifungal Research: Protocols and Troubles

  2026-08-04

  Ibrexafungerp (MK 3118) is redefining antifungal workflows by targeting resistant Candida strains, including those impervious to echinocandins and azoles. This article delivers actionable protocols, comparative insights, and troubleshooting strategies that maximize the translational power of this orally available, non-competitive glucan synthase inhibitor.

• Annexin V-Cy5 Apoptosis Kit: Illuminating Microglial Resilie

  2026-08-03

  Discover how the Annexin V-Cy5 Apoptosis Kit enables rigorous, high-sensitivity apoptosis detection in complex models like reversible microglial lysosomal stress. This in-depth article explores the assay’s scientific foundations and unique role in distinguishing apoptotic from non-apoptotic cellular responses.

• Tunable Human Intestinal Organoids: Balancing Self-Renewal a

  2026-08-03

  This study demonstrates a robust organoid culture system achieving a controlled balance between stem cell self-renewal and differentiation by leveraging targeted small molecule modulation. The optimized platform increases cellular diversity and proliferative capacity, advancing the scalability and physiological relevance of human intestinal organoid models for disease modeling and high-throughput research.

• Applied Cancer Models with Anti-ROR1 Antibody (Zilovertamab)

  2026-08-02

  Anti-ROR1 Antibody (Zilovertamab) empowers researchers to dissect Wnt5a-induced ROR1 signaling and anti-tumor responses in both in vitro and in vivo settings. Its high specificity, stability, and versatility streamline ELISA, FACS, and functional assays, offering robust solutions for model optimization and troubleshooting.

• Docosahexaenoic Acid (DHA) in Neuroprotection Research

  2026-08-01

  Docosahexaenoic Acid (DHA) stands out as a neuroprotective omega-3 fatty acid, essential for experimental models targeting cognitive dysfunction and hippocampal lipid homeostasis. This article translates recent spatial metabolomics insights into actionable protocols and advanced troubleshooting for researchers leveraging DHA in neuroinflammation and apoptosis studies.

• SB 431542: ALK5 Inhibitor Workflows for Organoids & Immunolo

  2026-07-31

  SB 431542 is redefining control over TGF-β signaling in organoid and immune assays, enabling precise manipulation of cell fate and spatial organization. This article reveals optimized protocols, troubleshooting strategies, and advanced use-cases that leverage SB 431542’s selectivity for ALK5.

• Biotin-HPDP in Neural Palmitoylation: Tools for Circuit Mapp

  2026-07-31

  Explore how Biotin-HPDP enables high-specificity labeling of palmitoylated proteins in neuroscience, bridging reversible thiol modification with advanced circuit mapping. This article reveals unique assay strategies and insights inspired by cutting-edge palmitoylation research.

• Applied Use-Cases for Anti-ROR1 Antibody (Zilovertamab) in C

  2026-07-30

  Anti-ROR1 Antibody (Zilovertamab) from APExBIO stands out for its high specificity and functional blocking of Wnt5a-induced ROR1 signaling, making it a critical tool in advanced cancer research. This article translates recent mechanistic insights into practical workflows, troubleshooting, and optimized protocols for immunoassays and in vivo studies.

• AP1903: Precision FKBP-Binding Ligand for Controlled Protein

  2026-07-30

  AP1903, a synthetic FKBP-binding ligand from APExBIO, enables nanomolar-precision control over FKBP fusion proteins for apoptosis pathway research and conditional cell ablation. This article details workflow refinements, troubleshooting insights, and cross-domain innovations, drawing on recent advances in high-throughput virus-host compatibility assays.

• MiR-3180 Suppresses HCC by Inhibiting Lipid Synthesis and Up

  2026-07-29

  Hong et al. (2023) establish miR-3180 as a key suppressor of hepatocellular carcinoma (HCC) growth and metastasis through dual inhibition of lipid synthesis and fatty acid uptake. Their work identifies miR-3180 as a negative regulator of SCD1 and CD36, providing both mechanistic insight and prognostic value for HCC treatment strategies.

• Marein Reverses ABCG2-Mediated Drug Resistance in Cancer Cel

  2026-07-29

  The reference study identifies marein, a flavonoid from Coreopsis tinctoria, as a potent competitive inhibitor of the ABCG2 transporter, restoring chemosensitivity in resistant cancer cells. By elucidating marein's mechanism of binding and its impact on intracellular drug accumulation, the work offers a promising strategy for overcoming multidrug resistance in cancer chemotherapy.

• Gamma-linolenic Acid (GLA): Precision Tools for Inflammatory

  2026-07-28

  Explore the distinct role of gamma-linolenic acid (GLA) in anti-inflammatory research, focusing on robust protocol design and its application in disease modeling. This article delivers a scientific deep-dive into GLA’s molecular impact and guides advanced workflows.

• Ceftolozane Sulfate: Optimizing PK/PD and Resistance Assays

  2026-07-28

  Ceftolozane sulfate empowers researchers to dissect resistance mechanisms in multidrug-resistant Pseudomonas aeruginosa with high fidelity. This guide details robust experimental workflows, troubleshooting tips, and innovative PK/PD modeling strategies leveraging Ceftolozane’s unique stability and bactericidal profile.

• NBC19: Optimizing Inflammasome Assays with SKU BA6129

  2026-07-27

  NBC19 (SKU BA6129) is a nanomolar NLRP3 inflammasome inhibitor engineered for precise modulation of IL-1β release in preclinical models. This scenario-driven guide addresses the core experimental challenges researchers face—ranging from assay reproducibility to vendor selection—and demonstrates how NBC19 delivers reliable, data-backed solutions for inflammation research.

11572 records 1/772 page Next 12345 下5页 Last page